Journal article
Efficacy Outcomes in Patients Using Alefacept in the AWARE Study
Abstract
BACKGROUND: Alefacept has demonstrated efficacy in clinical trials of patients with chronic plaque psoriasis, either as monotherapy or combined with other treatment modalities such as phototherapy.
OBJECTIVE: AWARE (Amevive Wisdom Acquired from Real-World Evidence) is a multicenter, observational, phase IV Canadian registry of psoriasis patients treated with alefacept.
Authors
Landells I; Searles G; Bissonnette R; Shear NH; Vender R; Lui H
Journal
Journal of Cutaneous Medicine and Surgery, Vol. 13, No. 6_suppl, pp. s122–s130
Publisher
SAGE Publications
Publication Date
November 2009
DOI
10.2310/7750.2009.00030
ISSN
1203-4754